News & articles

Trump Vows to Ease Rules for Drug Makers, but Again Zeros In on Prices

Battered by public outrage over the rising costs of drugs in recent years, the drug industry has regarded Mr. Trump warily in recent weeks. Pharmaceutical and biotechnology stocks rallied after his election as investors bet that Mr. Trump would reduce corporate taxes and adopt more industry-friendly policies than his opponent, Hillary Clinton, who had made reducing drug prices a campaign issue.

But that optimism gave way to unease after Mr. Trump pledged to tackle the drug pricing issue himself, including raising the possibility of allowing Medicare to negotiate the prices of drugs directly, something the industry has long opposed.

Just a few weeks ago, Mr. Trump singled out the pharmaceutical industry for its high prices, accusing it of “getting away with murder.”

At the meeting Tuesday, Mr. Trump again referred to Medicare’s role,…

Read the full article from the author…

Leave a Reply

Your email address will not be published. Required fields are marked *

SelfHelpEA © 2017